Atlas Trials

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

Clinical trial NCT00990327 · TERMINATED

Trial details

NCT number
NCT00990327
Sponsor
Forest Laboratories
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Coronary Artery Disease
Start date
2009-11-01
Primary completion
2012-04-01
Enrollment
863

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.